Does TREAT give the boot to ESAs in the treatment of CKD anemia?
Singh
Ajay K
AK
D000740:Anemia / Q000097:blood / Q000188:drug therapy* / Q000209:etiology*; D002908:Chronic Disease; D000068256:Darbepoetin alfa; D000068817:Epoetin Alfa; D004912:Erythrocytes / Q000378:metabolism; D004921:Erythropoietin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006397:Hematinics / Q000009:adverse effects* / Q000627:therapeutic use*; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D007674:Kidney Diseases / Q000097:blood / Q000150:complications*; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins
D006397:Hematinics; D006454:Hemoglobins; D011994:Recombinant Proteins; C103998:epoetin beta; D004921:Erythropoietin; D000068256:Darbepoetin alfa; D000068817:Epoetin Alfa